nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—ABCC4—Sorafenib—liver cancer	0.321	0.598	CbGbCtD
Meloxicam—CYP2C8—Sorafenib—liver cancer	0.0919	0.171	CbGbCtD
Meloxicam—CYP2C9—Sorafenib—liver cancer	0.0641	0.119	CbGbCtD
Meloxicam—CYP3A4—Sorafenib—liver cancer	0.0373	0.0695	CbGbCtD
Meloxicam—CYP3A4—Doxorubicin—liver cancer	0.0226	0.0421	CbGbCtD
Meloxicam—Mood swings—Epirubicin—liver cancer	0.00055	0.00198	CcSEcCtD
Meloxicam—Pruritus—Sorafenib—liver cancer	0.000546	0.00197	CcSEcCtD
Meloxicam—Blood creatinine increased—Epirubicin—liver cancer	0.000544	0.00196	CcSEcCtD
Meloxicam—Dehydration—Epirubicin—liver cancer	0.00054	0.00195	CcSEcCtD
Meloxicam—Pain in extremity—Doxorubicin—liver cancer	0.000537	0.00194	CcSEcCtD
Meloxicam—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000537	0.00194	CcSEcCtD
Meloxicam—Liver function test abnormal—Epirubicin—liver cancer	0.000536	0.00193	CcSEcCtD
Meloxicam—Abdominal pain upper—Epirubicin—liver cancer	0.00053	0.00191	CcSEcCtD
Meloxicam—Affect lability—Doxorubicin—liver cancer	0.000529	0.00191	CcSEcCtD
Meloxicam—Diarrhoea—Sorafenib—liver cancer	0.000529	0.00191	CcSEcCtD
Meloxicam—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000523	0.00189	CcSEcCtD
Meloxicam—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000523	0.00189	CcSEcCtD
Meloxicam—Nasopharyngitis—Epirubicin—liver cancer	0.000519	0.00187	CcSEcCtD
Meloxicam—Face oedema—Doxorubicin—liver cancer	0.000519	0.00187	CcSEcCtD
Meloxicam—Gastritis—Epirubicin—liver cancer	0.000514	0.00185	CcSEcCtD
Meloxicam—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000512	0.00185	CcSEcCtD
Meloxicam—Dizziness—Sorafenib—liver cancer	0.000511	0.00184	CcSEcCtD
Meloxicam—Mood swings—Doxorubicin—liver cancer	0.000509	0.00184	CcSEcCtD
Meloxicam—Blood creatinine increased—Doxorubicin—liver cancer	0.000503	0.00182	CcSEcCtD
Meloxicam—Asthma—Epirubicin—liver cancer	0.000502	0.00181	CcSEcCtD
Meloxicam—Influenza—Epirubicin—liver cancer	0.000502	0.00181	CcSEcCtD
Meloxicam—Dehydration—Doxorubicin—liver cancer	0.0005	0.0018	CcSEcCtD
Meloxicam—Liver function test abnormal—Doxorubicin—liver cancer	0.000496	0.00179	CcSEcCtD
Meloxicam—Pancreatitis—Epirubicin—liver cancer	0.000492	0.00177	CcSEcCtD
Meloxicam—Vomiting—Sorafenib—liver cancer	0.000491	0.00177	CcSEcCtD
Meloxicam—Abdominal pain upper—Doxorubicin—liver cancer	0.000491	0.00177	CcSEcCtD
Meloxicam—Angina pectoris—Epirubicin—liver cancer	0.000489	0.00176	CcSEcCtD
Meloxicam—Rash—Sorafenib—liver cancer	0.000487	0.00176	CcSEcCtD
Meloxicam—Dermatitis—Sorafenib—liver cancer	0.000487	0.00175	CcSEcCtD
Meloxicam—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000484	0.00175	CcSEcCtD
Meloxicam—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000484	0.00175	CcSEcCtD
Meloxicam—Headache—Sorafenib—liver cancer	0.000484	0.00175	CcSEcCtD
Meloxicam—Bronchitis—Epirubicin—liver cancer	0.000483	0.00174	CcSEcCtD
Meloxicam—Nasopharyngitis—Doxorubicin—liver cancer	0.000481	0.00173	CcSEcCtD
Meloxicam—Pancytopenia—Epirubicin—liver cancer	0.000477	0.00172	CcSEcCtD
Meloxicam—Gastritis—Doxorubicin—liver cancer	0.000476	0.00172	CcSEcCtD
Meloxicam—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000474	0.00171	CcSEcCtD
Meloxicam—Upper respiratory tract infection—Epirubicin—liver cancer	0.000467	0.00168	CcSEcCtD
Meloxicam—Influenza—Doxorubicin—liver cancer	0.000464	0.00168	CcSEcCtD
Meloxicam—Asthma—Doxorubicin—liver cancer	0.000464	0.00168	CcSEcCtD
Meloxicam—Pollakiuria—Epirubicin—liver cancer	0.000464	0.00167	CcSEcCtD
Meloxicam—Nausea—Sorafenib—liver cancer	0.000459	0.00165	CcSEcCtD
Meloxicam—Photosensitivity reaction—Epirubicin—liver cancer	0.000458	0.00165	CcSEcCtD
Meloxicam—Weight increased—Epirubicin—liver cancer	0.000457	0.00165	CcSEcCtD
Meloxicam—Pancreatitis—Doxorubicin—liver cancer	0.000455	0.00164	CcSEcCtD
Meloxicam—Weight decreased—Epirubicin—liver cancer	0.000454	0.00164	CcSEcCtD
Meloxicam—Angina pectoris—Doxorubicin—liver cancer	0.000452	0.00163	CcSEcCtD
Meloxicam—Infestation NOS—Epirubicin—liver cancer	0.000448	0.00161	CcSEcCtD
Meloxicam—Drowsiness—Epirubicin—liver cancer	0.000448	0.00161	CcSEcCtD
Meloxicam—Infestation—Epirubicin—liver cancer	0.000448	0.00161	CcSEcCtD
Meloxicam—Bronchitis—Doxorubicin—liver cancer	0.000447	0.00161	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000444	0.0016	CcSEcCtD
Meloxicam—Pancytopenia—Doxorubicin—liver cancer	0.000441	0.00159	CcSEcCtD
Meloxicam—Renal failure—Epirubicin—liver cancer	0.00044	0.00159	CcSEcCtD
Meloxicam—Stomatitis—Epirubicin—liver cancer	0.000436	0.00157	CcSEcCtD
Meloxicam—Jaundice—Epirubicin—liver cancer	0.000436	0.00157	CcSEcCtD
Meloxicam—Urinary tract infection—Epirubicin—liver cancer	0.000435	0.00157	CcSEcCtD
Meloxicam—Conjunctivitis—Epirubicin—liver cancer	0.000435	0.00157	CcSEcCtD
Meloxicam—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000432	0.00156	CcSEcCtD
Meloxicam—Sweating—Epirubicin—liver cancer	0.000429	0.00155	CcSEcCtD
Meloxicam—Pollakiuria—Doxorubicin—liver cancer	0.000429	0.00155	CcSEcCtD
Meloxicam—Haematuria—Epirubicin—liver cancer	0.000427	0.00154	CcSEcCtD
Meloxicam—Photosensitivity reaction—Doxorubicin—liver cancer	0.000424	0.00153	CcSEcCtD
Meloxicam—Hepatobiliary disease—Epirubicin—liver cancer	0.000423	0.00153	CcSEcCtD
Meloxicam—Weight increased—Doxorubicin—liver cancer	0.000423	0.00152	CcSEcCtD
Meloxicam—Weight decreased—Doxorubicin—liver cancer	0.00042	0.00152	CcSEcCtD
Meloxicam—Sinusitis—Epirubicin—liver cancer	0.00042	0.00151	CcSEcCtD
Meloxicam—Agranulocytosis—Epirubicin—liver cancer	0.000418	0.00151	CcSEcCtD
Meloxicam—Infestation—Doxorubicin—liver cancer	0.000414	0.00149	CcSEcCtD
Meloxicam—Drowsiness—Doxorubicin—liver cancer	0.000414	0.00149	CcSEcCtD
Meloxicam—Infestation NOS—Doxorubicin—liver cancer	0.000414	0.00149	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000411	0.00148	CcSEcCtD
Meloxicam—Renal failure—Doxorubicin—liver cancer	0.000407	0.00147	CcSEcCtD
Meloxicam—Haemoglobin—Epirubicin—liver cancer	0.000404	0.00146	CcSEcCtD
Meloxicam—Stomatitis—Doxorubicin—liver cancer	0.000404	0.00146	CcSEcCtD
Meloxicam—Jaundice—Doxorubicin—liver cancer	0.000404	0.00146	CcSEcCtD
Meloxicam—Rhinitis—Epirubicin—liver cancer	0.000403	0.00145	CcSEcCtD
Meloxicam—Conjunctivitis—Doxorubicin—liver cancer	0.000403	0.00145	CcSEcCtD
Meloxicam—Urinary tract infection—Doxorubicin—liver cancer	0.000403	0.00145	CcSEcCtD
Meloxicam—Haemorrhage—Epirubicin—liver cancer	0.000402	0.00145	CcSEcCtD
Meloxicam—Hepatitis—Epirubicin—liver cancer	0.000402	0.00145	CcSEcCtD
Meloxicam—Pharyngitis—Epirubicin—liver cancer	0.000399	0.00144	CcSEcCtD
Meloxicam—Sweating—Doxorubicin—liver cancer	0.000397	0.00143	CcSEcCtD
Meloxicam—Urinary tract disorder—Epirubicin—liver cancer	0.000397	0.00143	CcSEcCtD
Meloxicam—Oedema peripheral—Epirubicin—liver cancer	0.000396	0.00143	CcSEcCtD
Meloxicam—Haematuria—Doxorubicin—liver cancer	0.000395	0.00142	CcSEcCtD
Meloxicam—Connective tissue disorder—Epirubicin—liver cancer	0.000395	0.00142	CcSEcCtD
Meloxicam—Urethral disorder—Epirubicin—liver cancer	0.000394	0.00142	CcSEcCtD
Meloxicam—Hepatobiliary disease—Doxorubicin—liver cancer	0.000392	0.00141	CcSEcCtD
Meloxicam—Sinusitis—Doxorubicin—liver cancer	0.000389	0.0014	CcSEcCtD
Meloxicam—Visual impairment—Epirubicin—liver cancer	0.000387	0.0014	CcSEcCtD
Meloxicam—Agranulocytosis—Doxorubicin—liver cancer	0.000386	0.00139	CcSEcCtD
Meloxicam—Erythema multiforme—Epirubicin—liver cancer	0.00038	0.00137	CcSEcCtD
Meloxicam—Eye disorder—Epirubicin—liver cancer	0.000376	0.00135	CcSEcCtD
Meloxicam—Tinnitus—Epirubicin—liver cancer	0.000375	0.00135	CcSEcCtD
Meloxicam—Haemoglobin—Doxorubicin—liver cancer	0.000374	0.00135	CcSEcCtD
Meloxicam—Flushing—Epirubicin—liver cancer	0.000373	0.00134	CcSEcCtD
Meloxicam—Cardiac disorder—Epirubicin—liver cancer	0.000373	0.00134	CcSEcCtD
Meloxicam—Rhinitis—Doxorubicin—liver cancer	0.000373	0.00134	CcSEcCtD
Meloxicam—Haemorrhage—Doxorubicin—liver cancer	0.000372	0.00134	CcSEcCtD
Meloxicam—Hepatitis—Doxorubicin—liver cancer	0.000372	0.00134	CcSEcCtD
Meloxicam—Pharyngitis—Doxorubicin—liver cancer	0.000369	0.00133	CcSEcCtD
Meloxicam—Urinary tract disorder—Doxorubicin—liver cancer	0.000367	0.00132	CcSEcCtD
Meloxicam—Oedema peripheral—Doxorubicin—liver cancer	0.000366	0.00132	CcSEcCtD
Meloxicam—Connective tissue disorder—Doxorubicin—liver cancer	0.000365	0.00132	CcSEcCtD
Meloxicam—Angiopathy—Epirubicin—liver cancer	0.000365	0.00131	CcSEcCtD
Meloxicam—Urethral disorder—Doxorubicin—liver cancer	0.000364	0.00131	CcSEcCtD
Meloxicam—Immune system disorder—Epirubicin—liver cancer	0.000363	0.00131	CcSEcCtD
Meloxicam—Mediastinal disorder—Epirubicin—liver cancer	0.000362	0.00131	CcSEcCtD
Meloxicam—Arrhythmia—Epirubicin—liver cancer	0.000359	0.00129	CcSEcCtD
Meloxicam—Visual impairment—Doxorubicin—liver cancer	0.000358	0.00129	CcSEcCtD
Meloxicam—Alopecia—Epirubicin—liver cancer	0.000355	0.00128	CcSEcCtD
Meloxicam—Mental disorder—Epirubicin—liver cancer	0.000352	0.00127	CcSEcCtD
Meloxicam—Erythema multiforme—Doxorubicin—liver cancer	0.000352	0.00127	CcSEcCtD
Meloxicam—Malnutrition—Epirubicin—liver cancer	0.00035	0.00126	CcSEcCtD
Meloxicam—Erythema—Epirubicin—liver cancer	0.00035	0.00126	CcSEcCtD
Meloxicam—Eye disorder—Doxorubicin—liver cancer	0.000347	0.00125	CcSEcCtD
Meloxicam—Tinnitus—Doxorubicin—liver cancer	0.000347	0.00125	CcSEcCtD
Meloxicam—Cardiac disorder—Doxorubicin—liver cancer	0.000345	0.00124	CcSEcCtD
Meloxicam—Flushing—Doxorubicin—liver cancer	0.000345	0.00124	CcSEcCtD
Meloxicam—Flatulence—Epirubicin—liver cancer	0.000345	0.00124	CcSEcCtD
Meloxicam—Tension—Epirubicin—liver cancer	0.000343	0.00124	CcSEcCtD
Meloxicam—Dysgeusia—Epirubicin—liver cancer	0.000343	0.00124	CcSEcCtD
Meloxicam—Nervousness—Epirubicin—liver cancer	0.00034	0.00123	CcSEcCtD
Meloxicam—Back pain—Epirubicin—liver cancer	0.000338	0.00122	CcSEcCtD
Meloxicam—Angiopathy—Doxorubicin—liver cancer	0.000337	0.00122	CcSEcCtD
Meloxicam—Muscle spasms—Epirubicin—liver cancer	0.000336	0.00121	CcSEcCtD
Meloxicam—Immune system disorder—Doxorubicin—liver cancer	0.000336	0.00121	CcSEcCtD
Meloxicam—Mediastinal disorder—Doxorubicin—liver cancer	0.000335	0.00121	CcSEcCtD
Meloxicam—Arrhythmia—Doxorubicin—liver cancer	0.000332	0.0012	CcSEcCtD
Meloxicam—Vision blurred—Epirubicin—liver cancer	0.00033	0.00119	CcSEcCtD
Meloxicam—Alopecia—Doxorubicin—liver cancer	0.000329	0.00118	CcSEcCtD
Meloxicam—Mental disorder—Doxorubicin—liver cancer	0.000326	0.00117	CcSEcCtD
Meloxicam—Ill-defined disorder—Epirubicin—liver cancer	0.000325	0.00117	CcSEcCtD
Meloxicam—Malnutrition—Doxorubicin—liver cancer	0.000324	0.00117	CcSEcCtD
Meloxicam—Erythema—Doxorubicin—liver cancer	0.000324	0.00117	CcSEcCtD
Meloxicam—Anaemia—Epirubicin—liver cancer	0.000323	0.00117	CcSEcCtD
Meloxicam—Flatulence—Doxorubicin—liver cancer	0.000319	0.00115	CcSEcCtD
Meloxicam—Tension—Doxorubicin—liver cancer	0.000318	0.00115	CcSEcCtD
Meloxicam—Dysgeusia—Doxorubicin—liver cancer	0.000317	0.00114	CcSEcCtD
Meloxicam—Malaise—Epirubicin—liver cancer	0.000315	0.00114	CcSEcCtD
Meloxicam—Nervousness—Doxorubicin—liver cancer	0.000314	0.00113	CcSEcCtD
Meloxicam—Vertigo—Epirubicin—liver cancer	0.000314	0.00113	CcSEcCtD
Meloxicam—Syncope—Epirubicin—liver cancer	0.000314	0.00113	CcSEcCtD
Meloxicam—Leukopenia—Epirubicin—liver cancer	0.000313	0.00113	CcSEcCtD
Meloxicam—Back pain—Doxorubicin—liver cancer	0.000313	0.00113	CcSEcCtD
Meloxicam—Muscle spasms—Doxorubicin—liver cancer	0.000311	0.00112	CcSEcCtD
Meloxicam—Palpitations—Epirubicin—liver cancer	0.000309	0.00111	CcSEcCtD
Meloxicam—Loss of consciousness—Epirubicin—liver cancer	0.000307	0.00111	CcSEcCtD
Meloxicam—Cough—Epirubicin—liver cancer	0.000305	0.0011	CcSEcCtD
Meloxicam—Vision blurred—Doxorubicin—liver cancer	0.000305	0.0011	CcSEcCtD
Meloxicam—Convulsion—Epirubicin—liver cancer	0.000303	0.00109	CcSEcCtD
Meloxicam—Hypertension—Epirubicin—liver cancer	0.000302	0.00109	CcSEcCtD
Meloxicam—Ill-defined disorder—Doxorubicin—liver cancer	0.0003	0.00108	CcSEcCtD
Meloxicam—Anaemia—Doxorubicin—liver cancer	0.000299	0.00108	CcSEcCtD
Meloxicam—Myalgia—Epirubicin—liver cancer	0.000298	0.00107	CcSEcCtD
Meloxicam—Arthralgia—Epirubicin—liver cancer	0.000298	0.00107	CcSEcCtD
Meloxicam—Anxiety—Epirubicin—liver cancer	0.000297	0.00107	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000296	0.00107	CcSEcCtD
Meloxicam—Discomfort—Epirubicin—liver cancer	0.000294	0.00106	CcSEcCtD
Meloxicam—Malaise—Doxorubicin—liver cancer	0.000292	0.00105	CcSEcCtD
Meloxicam—Dry mouth—Epirubicin—liver cancer	0.000291	0.00105	CcSEcCtD
Meloxicam—Vertigo—Doxorubicin—liver cancer	0.000291	0.00105	CcSEcCtD
Meloxicam—Syncope—Doxorubicin—liver cancer	0.00029	0.00105	CcSEcCtD
Meloxicam—Leukopenia—Doxorubicin—liver cancer	0.00029	0.00104	CcSEcCtD
Meloxicam—Confusional state—Epirubicin—liver cancer	0.000288	0.00104	CcSEcCtD
Meloxicam—Palpitations—Doxorubicin—liver cancer	0.000286	0.00103	CcSEcCtD
Meloxicam—Oedema—Epirubicin—liver cancer	0.000285	0.00103	CcSEcCtD
Meloxicam—Anaphylactic shock—Epirubicin—liver cancer	0.000285	0.00103	CcSEcCtD
Meloxicam—Loss of consciousness—Doxorubicin—liver cancer	0.000284	0.00103	CcSEcCtD
Meloxicam—Infection—Epirubicin—liver cancer	0.000284	0.00102	CcSEcCtD
Meloxicam—Cough—Doxorubicin—liver cancer	0.000282	0.00102	CcSEcCtD
Meloxicam—Shock—Epirubicin—liver cancer	0.000281	0.00101	CcSEcCtD
Meloxicam—Convulsion—Doxorubicin—liver cancer	0.00028	0.00101	CcSEcCtD
Meloxicam—Nervous system disorder—Epirubicin—liver cancer	0.00028	0.00101	CcSEcCtD
Meloxicam—Thrombocytopenia—Epirubicin—liver cancer	0.00028	0.00101	CcSEcCtD
Meloxicam—Hypertension—Doxorubicin—liver cancer	0.000279	0.00101	CcSEcCtD
Meloxicam—Tachycardia—Epirubicin—liver cancer	0.000279	0.001	CcSEcCtD
Meloxicam—Skin disorder—Epirubicin—liver cancer	0.000277	0.001	CcSEcCtD
Meloxicam—Hyperhidrosis—Epirubicin—liver cancer	0.000276	0.000995	CcSEcCtD
Meloxicam—Arthralgia—Doxorubicin—liver cancer	0.000276	0.000994	CcSEcCtD
Meloxicam—Myalgia—Doxorubicin—liver cancer	0.000276	0.000994	CcSEcCtD
Meloxicam—Anxiety—Doxorubicin—liver cancer	0.000275	0.00099	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000274	0.000987	CcSEcCtD
Meloxicam—Discomfort—Doxorubicin—liver cancer	0.000272	0.000982	CcSEcCtD
Meloxicam—Dry mouth—Doxorubicin—liver cancer	0.000269	0.000972	CcSEcCtD
Meloxicam—Hypotension—Epirubicin—liver cancer	0.000267	0.000962	CcSEcCtD
Meloxicam—Confusional state—Doxorubicin—liver cancer	0.000266	0.00096	CcSEcCtD
Meloxicam—Oedema—Doxorubicin—liver cancer	0.000264	0.000953	CcSEcCtD
Meloxicam—Anaphylactic shock—Doxorubicin—liver cancer	0.000264	0.000953	CcSEcCtD
Meloxicam—Infection—Doxorubicin—liver cancer	0.000262	0.000946	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00026	0.000938	CcSEcCtD
Meloxicam—Shock—Doxorubicin—liver cancer	0.00026	0.000937	CcSEcCtD
Meloxicam—Nervous system disorder—Doxorubicin—liver cancer	0.000259	0.000934	CcSEcCtD
Meloxicam—Thrombocytopenia—Doxorubicin—liver cancer	0.000259	0.000933	CcSEcCtD
Meloxicam—Insomnia—Epirubicin—liver cancer	0.000258	0.000931	CcSEcCtD
Meloxicam—Tachycardia—Doxorubicin—liver cancer	0.000258	0.00093	CcSEcCtD
Meloxicam—Skin disorder—Doxorubicin—liver cancer	0.000257	0.000925	CcSEcCtD
Meloxicam—Paraesthesia—Epirubicin—liver cancer	0.000256	0.000924	CcSEcCtD
Meloxicam—Hyperhidrosis—Doxorubicin—liver cancer	0.000255	0.000921	CcSEcCtD
Meloxicam—Dyspnoea—Epirubicin—liver cancer	0.000255	0.000918	CcSEcCtD
Meloxicam—Somnolence—Epirubicin—liver cancer	0.000254	0.000915	CcSEcCtD
Meloxicam—Dyspepsia—Epirubicin—liver cancer	0.000251	0.000906	CcSEcCtD
Meloxicam—Decreased appetite—Epirubicin—liver cancer	0.000248	0.000895	CcSEcCtD
Meloxicam—Hypotension—Doxorubicin—liver cancer	0.000247	0.00089	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Epirubicin—liver cancer	0.000246	0.000889	CcSEcCtD
Meloxicam—Fatigue—Epirubicin—liver cancer	0.000246	0.000888	CcSEcCtD
Meloxicam—Constipation—Epirubicin—liver cancer	0.000244	0.00088	CcSEcCtD
Meloxicam—Pain—Epirubicin—liver cancer	0.000244	0.00088	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000241	0.000868	CcSEcCtD
Meloxicam—Insomnia—Doxorubicin—liver cancer	0.000239	0.000862	CcSEcCtD
Meloxicam—Paraesthesia—Doxorubicin—liver cancer	0.000237	0.000855	CcSEcCtD
Meloxicam—Dyspnoea—Doxorubicin—liver cancer	0.000235	0.000849	CcSEcCtD
Meloxicam—Feeling abnormal—Epirubicin—liver cancer	0.000235	0.000848	CcSEcCtD
Meloxicam—Somnolence—Doxorubicin—liver cancer	0.000235	0.000847	CcSEcCtD
Meloxicam—Gastrointestinal pain—Epirubicin—liver cancer	0.000233	0.000842	CcSEcCtD
Meloxicam—Dyspepsia—Doxorubicin—liver cancer	0.000233	0.000838	CcSEcCtD
Meloxicam—Decreased appetite—Doxorubicin—liver cancer	0.00023	0.000828	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000228	0.000822	CcSEcCtD
Meloxicam—Fatigue—Doxorubicin—liver cancer	0.000228	0.000821	CcSEcCtD
Meloxicam—Urticaria—Epirubicin—liver cancer	0.000227	0.000818	CcSEcCtD
Meloxicam—Constipation—Doxorubicin—liver cancer	0.000226	0.000815	CcSEcCtD
Meloxicam—Pain—Doxorubicin—liver cancer	0.000226	0.000815	CcSEcCtD
Meloxicam—Abdominal pain—Epirubicin—liver cancer	0.000226	0.000814	CcSEcCtD
Meloxicam—Body temperature increased—Epirubicin—liver cancer	0.000226	0.000814	CcSEcCtD
Meloxicam—Feeling abnormal—Doxorubicin—liver cancer	0.000218	0.000785	CcSEcCtD
Meloxicam—Gastrointestinal pain—Doxorubicin—liver cancer	0.000216	0.000779	CcSEcCtD
Meloxicam—Hypersensitivity—Epirubicin—liver cancer	0.00021	0.000758	CcSEcCtD
Meloxicam—Urticaria—Doxorubicin—liver cancer	0.00021	0.000757	CcSEcCtD
Meloxicam—Abdominal pain—Doxorubicin—liver cancer	0.000209	0.000753	CcSEcCtD
Meloxicam—Body temperature increased—Doxorubicin—liver cancer	0.000209	0.000753	CcSEcCtD
Meloxicam—Asthenia—Epirubicin—liver cancer	0.000205	0.000739	CcSEcCtD
Meloxicam—Pruritus—Epirubicin—liver cancer	0.000202	0.000728	CcSEcCtD
Meloxicam—Diarrhoea—Epirubicin—liver cancer	0.000195	0.000704	CcSEcCtD
Meloxicam—Hypersensitivity—Doxorubicin—liver cancer	0.000195	0.000702	CcSEcCtD
Meloxicam—Asthenia—Doxorubicin—liver cancer	0.00019	0.000683	CcSEcCtD
Meloxicam—Dizziness—Epirubicin—liver cancer	0.000189	0.000681	CcSEcCtD
Meloxicam—Pruritus—Doxorubicin—liver cancer	0.000187	0.000674	CcSEcCtD
Meloxicam—Vomiting—Epirubicin—liver cancer	0.000182	0.000655	CcSEcCtD
Meloxicam—Diarrhoea—Doxorubicin—liver cancer	0.000181	0.000652	CcSEcCtD
Meloxicam—Rash—Epirubicin—liver cancer	0.00018	0.000649	CcSEcCtD
Meloxicam—Dermatitis—Epirubicin—liver cancer	0.00018	0.000649	CcSEcCtD
Meloxicam—Headache—Epirubicin—liver cancer	0.000179	0.000645	CcSEcCtD
Meloxicam—Dizziness—Doxorubicin—liver cancer	0.000175	0.00063	CcSEcCtD
Meloxicam—Nausea—Epirubicin—liver cancer	0.00017	0.000612	CcSEcCtD
Meloxicam—Vomiting—Doxorubicin—liver cancer	0.000168	0.000606	CcSEcCtD
Meloxicam—Rash—Doxorubicin—liver cancer	0.000167	0.000601	CcSEcCtD
Meloxicam—Dermatitis—Doxorubicin—liver cancer	0.000166	0.0006	CcSEcCtD
Meloxicam—Headache—Doxorubicin—liver cancer	0.000165	0.000597	CcSEcCtD
Meloxicam—Nausea—Doxorubicin—liver cancer	0.000157	0.000566	CcSEcCtD
Meloxicam—PGD—Metabolism—PIK3CB—liver cancer	6.23e-05	0.000335	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—GSTM1—liver cancer	6.23e-05	0.000335	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—NAT2—liver cancer	6.22e-05	0.000335	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	6.14e-05	0.000331	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CPT1B—liver cancer	6.13e-05	0.00033	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GLUL—liver cancer	6.13e-05	0.00033	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CB—liver cancer	6.12e-05	0.000329	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—ALB—liver cancer	6e-05	0.000323	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	5.98e-05	0.000322	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—TAT—liver cancer	5.97e-05	0.000321	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALDOB—liver cancer	5.96e-05	0.000321	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL6—liver cancer	5.92e-05	0.000319	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—AKT1—liver cancer	5.91e-05	0.000318	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NR1H4—liver cancer	5.91e-05	0.000318	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—CYP1A1—liver cancer	5.9e-05	0.000318	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	5.87e-05	0.000316	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	5.82e-05	0.000313	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	5.82e-05	0.000313	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTA3—liver cancer	5.81e-05	0.000313	CbGpPWpGaD
Meloxicam—PGD—Disease—STAT3—liver cancer	5.75e-05	0.000309	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CRABP1—liver cancer	5.69e-05	0.000306	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ALDOB—liver cancer	5.65e-05	0.000304	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—IL2—liver cancer	5.62e-05	0.000302	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—RAF1—liver cancer	5.43e-05	0.000292	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—liver cancer	5.4e-05	0.000291	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	5.36e-05	0.000288	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	5.35e-05	0.000288	CbGpPWpGaD
Meloxicam—PGD—Disease—MYC—liver cancer	5.34e-05	0.000288	CbGpPWpGaD
Meloxicam—PGD—Disease—TGFB1—liver cancer	5.33e-05	0.000287	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTA4—liver cancer	5.31e-05	0.000286	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.19e-05	0.000279	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTA2—liver cancer	5.18e-05	0.000279	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.12e-05	0.000276	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTA1—liver cancer	4.99e-05	0.000269	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	4.99e-05	0.000269	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CPT1B—liver cancer	4.98e-05	0.000268	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GLUL—liver cancer	4.98e-05	0.000268	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—HPGDS—liver cancer	4.97e-05	0.000268	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	4.95e-05	0.000266	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.94e-05	0.000266	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NAT2—liver cancer	4.94e-05	0.000266	CbGpPWpGaD
Meloxicam—PGD—Disease—KRAS—liver cancer	4.94e-05	0.000266	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NR1H4—liver cancer	4.81e-05	0.000259	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—VEGFA—liver cancer	4.78e-05	0.000257	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.75e-05	0.000256	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALDOB—liver cancer	4.73e-05	0.000255	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTA3—liver cancer	4.73e-05	0.000254	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	4.55e-05	0.000245	CbGpPWpGaD
Meloxicam—PGD—Disease—PIK3CA—liver cancer	4.54e-05	0.000244	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CRABP1—liver cancer	4.52e-05	0.000243	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.5e-05	0.000242	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ADAM17—liver cancer	4.47e-05	0.00024	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.45e-05	0.000239	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PSMD10—liver cancer	4.43e-05	0.000239	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PSMA4—liver cancer	4.43e-05	0.000239	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—UGDH—liver cancer	4.42e-05	0.000238	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	4.4e-05	0.000237	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.39e-05	0.000236	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TGFB1—liver cancer	4.38e-05	0.000236	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTA4—liver cancer	4.32e-05	0.000233	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GOT2—liver cancer	4.31e-05	0.000232	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	4.22e-05	0.000227	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTA2—liver cancer	4.21e-05	0.000227	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PSMA4—liver cancer	4.2e-05	0.000226	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PSMD10—liver cancer	4.2e-05	0.000226	CbGpPWpGaD
Meloxicam—PGD—Disease—HRAS—liver cancer	4.2e-05	0.000226	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—EPT1—liver cancer	4.15e-05	0.000223	CbGpPWpGaD
Meloxicam—PTGS2—Disease—GOT2—liver cancer	4.09e-05	0.00022	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.07e-05	0.000219	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTA1—liver cancer	4.06e-05	0.000219	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—KRAS—liver cancer	4.06e-05	0.000219	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GLUL—liver cancer	4.06e-05	0.000218	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CPT1B—liver cancer	4.06e-05	0.000218	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP2E1—liver cancer	4.05e-05	0.000218	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NAT2—liver cancer	4.02e-05	0.000216	CbGpPWpGaD
Meloxicam—PGD—Disease—IL6—liver cancer	4.02e-05	0.000216	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—HPGDS—liver cancer	3.95e-05	0.000212	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—TAT—liver cancer	3.94e-05	0.000212	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.92e-05	0.000211	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.92e-05	0.000211	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NR1H4—liver cancer	3.91e-05	0.000211	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.86e-05	0.000208	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALDOB—liver cancer	3.85e-05	0.000207	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTA3—liver cancer	3.85e-05	0.000207	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PIK3CA—liver cancer	3.8e-05	0.000204	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYCS—liver cancer	3.79e-05	0.000204	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CA—liver cancer	3.73e-05	0.000201	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GOT1—liver cancer	3.72e-05	0.0002	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GGT1—liver cancer	3.72e-05	0.0002	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.72e-05	0.0002	CbGpPWpGaD
Meloxicam—PGD—Disease—AKT1—liver cancer	3.71e-05	0.000199	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CRABP1—liver cancer	3.67e-05	0.000198	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TP53—liver cancer	3.61e-05	0.000194	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.57e-05	0.000192	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.53e-05	0.00019	CbGpPWpGaD
Meloxicam—PTGS2—Disease—GOT1—liver cancer	3.53e-05	0.00019	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PSMA4—liver cancer	3.52e-05	0.000189	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PSMD10—liver cancer	3.52e-05	0.000189	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTA4—liver cancer	3.52e-05	0.000189	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—HRAS—liver cancer	3.45e-05	0.000186	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.44e-05	0.000185	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTA2—liver cancer	3.43e-05	0.000184	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GOT2—liver cancer	3.42e-05	0.000184	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTP1—liver cancer	3.34e-05	0.00018	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.31e-05	0.000178	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTA1—liver cancer	3.31e-05	0.000178	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—HMOX1—liver cancer	3.3e-05	0.000177	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NAT2—liver cancer	3.27e-05	0.000176	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PRKCE—liver cancer	3.25e-05	0.000175	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP2E1—liver cancer	3.22e-05	0.000173	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—HPGDS—liver cancer	3.21e-05	0.000173	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.19e-05	0.000172	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.14e-05	0.000169	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALDOB—liver cancer	3.14e-05	0.000169	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.12e-05	0.000168	CbGpPWpGaD
Meloxicam—PGD—Metabolism—AKT1—liver cancer	3.1e-05	0.000167	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTM1—liver cancer	3.07e-05	0.000165	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—AKT1—liver cancer	3.05e-05	0.000164	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYCS—liver cancer	3.01e-05	0.000162	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CRABP1—liver cancer	2.99e-05	0.000161	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GGT1—liver cancer	2.95e-05	0.000159	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GOT1—liver cancer	2.95e-05	0.000159	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP1A1—liver cancer	2.91e-05	0.000157	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.91e-05	0.000157	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.87e-05	0.000155	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PSMA4—liver cancer	2.86e-05	0.000154	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PSMD10—liver cancer	2.86e-05	0.000154	CbGpPWpGaD
Meloxicam—PTGS2—Disease—H2AFX—liver cancer	2.84e-05	0.000153	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GOT2—liver cancer	2.79e-05	0.00015	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—MTHFR—liver cancer	2.72e-05	0.000146	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.69e-05	0.000145	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GLUL—liver cancer	2.68e-05	0.000144	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CPT1B—liver cancer	2.68e-05	0.000144	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PPARA—liver cancer	2.66e-05	0.000143	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTP1—liver cancer	2.65e-05	0.000143	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP2E1—liver cancer	2.62e-05	0.000141	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—HMOX1—liver cancer	2.62e-05	0.000141	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HPGDS—liver cancer	2.61e-05	0.000141	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.6e-05	0.00014	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NR1H4—liver cancer	2.58e-05	0.000139	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MTHFR—liver cancer	2.57e-05	0.000139	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TERT—liver cancer	2.57e-05	0.000138	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTA3—liver cancer	2.54e-05	0.000137	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.54e-05	0.000136	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYCS—liver cancer	2.45e-05	0.000132	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTM1—liver cancer	2.44e-05	0.000131	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GOT1—liver cancer	2.4e-05	0.000129	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GGT1—liver cancer	2.4e-05	0.000129	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.39e-05	0.000129	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.37e-05	0.000127	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.34e-05	0.000126	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PSMD10—liver cancer	2.33e-05	0.000125	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PSMA4—liver cancer	2.33e-05	0.000125	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTA4—liver cancer	2.32e-05	0.000125	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP1A1—liver cancer	2.31e-05	0.000124	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CG—liver cancer	2.28e-05	0.000123	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GOT2—liver cancer	2.27e-05	0.000122	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTA2—liver cancer	2.26e-05	0.000122	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PPARG—liver cancer	2.2e-05	0.000118	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTA1—liver cancer	2.18e-05	0.000117	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APC—liver cancer	2.16e-05	0.000116	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTP1—liver cancer	2.16e-05	0.000116	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NAT2—liver cancer	2.16e-05	0.000116	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—MTHFR—liver cancer	2.16e-05	0.000116	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP2E1—liver cancer	2.13e-05	0.000115	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—HMOX1—liver cancer	2.13e-05	0.000115	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPARA—liver cancer	2.11e-05	0.000114	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALDOB—liver cancer	2.07e-05	0.000111	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.06e-05	0.000111	CbGpPWpGaD
Meloxicam—PTGS2—Disease—BRAF—liver cancer	2.03e-05	0.000109	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CD—liver cancer	2.01e-05	0.000108	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYCS—liver cancer	1.99e-05	0.000107	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTM1—liver cancer	1.98e-05	0.000107	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALB—liver cancer	1.98e-05	0.000107	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CRABP1—liver cancer	1.97e-05	0.000106	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GGT1—liver cancer	1.96e-05	0.000105	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GOT1—liver cancer	1.96e-05	0.000105	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CD—liver cancer	1.9e-05	0.000102	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.9e-05	0.000102	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP1A1—liver cancer	1.88e-05	0.000101	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SERPINE1—liver cancer	1.88e-05	0.000101	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CG—liver cancer	1.81e-05	9.75e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTP1—liver cancer	1.76e-05	9.46e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—MTHFR—liver cancer	1.75e-05	9.44e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CB—liver cancer	1.75e-05	9.41e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPARG—liver cancer	1.75e-05	9.41e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HMOX1—liver cancer	1.73e-05	9.33e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HPGDS—liver cancer	1.72e-05	9.28e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPARA—liver cancer	1.72e-05	9.26e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—RAF1—liver cancer	1.7e-05	9.13e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CB—liver cancer	1.66e-05	8.92e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MTOR—liver cancer	1.66e-05	8.92e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTM1—liver cancer	1.62e-05	8.69e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CD—liver cancer	1.59e-05	8.57e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALB—liver cancer	1.57e-05	8.46e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN1B—liver cancer	1.55e-05	8.37e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.55e-05	8.32e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PSMA4—liver cancer	1.54e-05	8.27e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PSMD10—liver cancer	1.54e-05	8.27e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP1A1—liver cancer	1.53e-05	8.24e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GOT2—liver cancer	1.49e-05	8.04e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CG—liver cancer	1.47e-05	7.93e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CTNNB1—liver cancer	1.47e-05	7.91e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN1A—liver cancer	1.44e-05	7.72e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—MTHFR—liver cancer	1.43e-05	7.68e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPARG—liver cancer	1.42e-05	7.65e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP2E1—liver cancer	1.41e-05	7.56e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPARA—liver cancer	1.4e-05	7.54e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CB—liver cancer	1.39e-05	7.47e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYCS—liver cancer	1.32e-05	7.08e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CD—liver cancer	1.3e-05	6.97e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GOT1—liver cancer	1.29e-05	6.94e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GGT1—liver cancer	1.29e-05	6.94e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—STAT3—liver cancer	1.28e-05	6.89e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALB—liver cancer	1.28e-05	6.88e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.26e-05	6.77e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CG—liver cancer	1.2e-05	6.45e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MYC—liver cancer	1.19e-05	6.4e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TGFB1—liver cancer	1.19e-05	6.39e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTP1—liver cancer	1.16e-05	6.24e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPARG—liver cancer	1.16e-05	6.23e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HMOX1—liver cancer	1.14e-05	6.15e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CB—liver cancer	1.13e-05	6.08e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—KRAS—liver cancer	1.1e-05	5.92e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CA—liver cancer	1.07e-05	5.73e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTM1—liver cancer	1.07e-05	5.73e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CD—liver cancer	1.05e-05	5.67e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALB—liver cancer	1.04e-05	5.6e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CA—liver cancer	1.01e-05	5.44e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP1A1—liver cancer	1.01e-05	5.43e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—MTHFR—liver cancer	9.41e-06	5.07e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HRAS—liver cancer	9.35e-06	5.03e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPARA—liver cancer	9.24e-06	4.97e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CB—liver cancer	9.19e-06	4.95e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6—liver cancer	8.94e-06	4.81e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—AKT1—liver cancer	8.7e-06	4.68e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CA—liver cancer	8.46e-06	4.55e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—AKT1—liver cancer	8.25e-06	4.44e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CG—liver cancer	7.91e-06	4.26e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPARG—liver cancer	7.63e-06	4.11e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CD—liver cancer	6.95e-06	3.74e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—AKT1—liver cancer	6.91e-06	3.72e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CA—liver cancer	6.88e-06	3.7e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALB—liver cancer	6.86e-06	3.69e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CB—liver cancer	6.06e-06	3.26e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—AKT1—liver cancer	5.62e-06	3.03e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CA—liver cancer	5.6e-06	3.01e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—AKT1—liver cancer	4.58e-06	2.46e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CA—liver cancer	3.69e-06	1.99e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—AKT1—liver cancer	3.02e-06	1.62e-05	CbGpPWpGaD
